Skip to main content
OpenTrials
Completed

NCT Number: NCT00824629

Embryo Transfer: Direct Versus Afterloading Trial

The purpose of this study is to evaluate two types of embryo transfer procedure.

The investigators will compare direct embryo transfer against afterloading embryo transfer.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–42 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Departamento de Obstetricia Ginecologia y Reproducción. Institut Universitari Dexeus

Barcelona, 08037, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients in IVF/CICSI program
  • Transfer day:2 or 3 after ovum pick-up

Exclusion criteria

  • None

Treatment and study plan

Afterloading embryo transfer procedure

Procedure

Afterloading embryo transfer procedure

Direct embryo transfer procedure

Procedure

Direct embryo transfer procedure

Primary outcomes

  1. Clinical pregnancy

    Time frame: 8 weeks after embryo transfer

Secondary outcomes

  1. Difficulty of embryo transfer

    Time frame: During embryo transfer procedure

  2. Duration of embryo transfer

    Time frame: During embryo transfer procedure

Sponsors and collaborators

Lead sponsor

Fundacion Dexeus

Other

Registry information

Official study title

Direct Transfer vs Previous Cervical Canalization Transfer ("Afterloading"): Randomized Clinical Trial.

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
Jan 19, 2009
Registry last updated
Oct 26, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.